Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
企業コードTKNO
会社名Alpha Teknova Inc
上場日Jun 25, 2021
最高経営責任者「CEO」Mr. Stephen Gunstream
従業員数173
証券種類Ordinary Share
決算期末Jun 25
本社所在地2451 Bert Drive
都市HOLLISTER
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号95023
電話番号18316371100
ウェブサイトhttps://www.teknova.com/
企業コードTKNO
上場日Jun 25, 2021
最高経営責任者「CEO」Mr. Stephen Gunstream
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし